ז'בלור
国家: 以色列
语言: 希伯来文
来源: Ministry of Health
该产品的某些文档当前不可用，您可以向我们的客户服务发送请求，我们将在获得它们后尽快通知您。
发送请求。
发送请求。
有效成分:
VINFLUNINE DITARTRATE
可用日期:
PERRIGO ISRAEL AGENCIES LTD
ATC代码:
L01CA05
药物剂型:
תרכיז להכנת תמיסה לאינפוזיה
组成:
VINFLUNINE DITARTRATE 25 MG/ML
给药途径:
תוך-ורידי
处方类型:
מרשם נדרש
厂商:
PIERRE FABRE MEDICAMENT PRODUCTION, FRANCE
治疗组:
VINFLUNINE
治疗领域:
VINFLUNINE
疗效迹象:
Javlor is indicated in monotherapy for the treatment of adult patients with advanced or metastatic transitional cell carcinoma of the urothelial tract after failure of a prior platinium-containing regimen. Efficacy and safety of vinflunine have not been studied in patients with Performance Status ?2.
授权日期:
2017-08-31
